Type 2 Diabetes Trial, By Invitation NCT06856720 Sponsor: University of Salamanca Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, By Invitation

NCT06856720
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with type 2 diabetes.
  • People who are 60 years of age or older.
  • People who live in a nursing home or similar long-term care facility in Portugal.
  • People who are able to understand what the study involves and agree to take part by giving their informed consent.
  • People whose diabetes medication has remained unchanged for at least 12 weeks before joining the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with severe memory or thinking difficulties that prevent them from giving informed consent.
  • People who have a sudden or unstable health condition that would make taking part unsafe.
  • People for whom moderate-intensity exercise is not considered safe or appropriate (confirm with trial site).
  • People who have an implanted electronic device, such as a pacemaker or a heart device that corrects abnormal rhythms.
  • People who have wounds, sores, or skin conditions in areas where electrodes (small sensor pads placed on the skin) would need to be applied.
  • People whose treating clinical team determines that any other condition makes safe participation in the trial not possible.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
University of Salamanca
Registry
ClinicalTrials.gov
Start date
27 October 2025
Est. completion
30 August 2026

Where this trial is recruiting

🇵🇹 Portugal

Primary endpoints

Weekly Mean Fasting Capillary Glucose

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov